0.5 Mg Trametinib Tablets

Name: 0.5 Mg Trametinib Tablets
Brand: NEETCO BIOPHARMA
Price: 48000 INR
Availability: InStock

Price 48000 INR/ Box

Get a Price/Quote

MOQ : 1 Box

0.5 Mg Trametinib Tablets Specification

Indication
Treatment of metastatic melanoma and other cancers with BRAF V600E or V600K mutations

Dosage Form
Tablet

Salt Composition
Trametinib 0.5 mg

Feature
Film-coated, precision dosage, oral administration

Ingredients
Trametinib and excipients

Application
Antineoplastic agent for oral administration

Physical Color/Texture
Light yellow, film-coated tablet

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 months

About 0.5 Mg Trametinib Tablets

Unlock first-class cancer care with Trametinib Tablets 0.5 mg, your premier choice for precision oncology. Highlighted for their value and top-ranking efficacy, these incomparable, film-coated tablets are boxed in convenient blister strips, ensuring every dose is protected. Approved for adult patients with metastatic melanoma or select BRAF V600 mutations, each tablet is precisely formulated for oral administration. Only available with a prescription, these tablets offer a clinically trusted solution-consult an oncologist before use. Experience excellence in antineoplastic therapy, distributed by a leading supplier from India, with every box.

Application & Uses: Precision Oncology with 0.5 Mg Trametinib Tablets

0.5 Mg Trametinib Tablets unlock advanced antineoplastic applications in oncology, focusing on the management of metastatic melanoma and cancers exhibiting BRAF V600E or V600K mutations. Specially developed for commercial healthcare environments, these film-coated tablets offer value with their precision dosage and targeted action. Their main application is in adult patients, under professional supervision, providing healthcare providers a top-ranking solution for tailored cancer therapy in hospital and clinical settings worldwide.

Delivery Assurance and Export Markets for 0.5 Mg Trametinib Tablets

Order completion for 0.5 Mg Trametinib Tablets is streamlined for efficiency, ensuring stock is ready for prompt dispatch. Goods transport is handled via secured, temperature-controlled channels to preserve product integrity. Major export markets include North America, Europe, Asia, and Africa. Sample availability supports product verification prior to bulk orders, facilitating seamless international trade. Buyers can rely on timely delivery and professional packaging to meet diverse commercial demands across global healthcare sectors.

FAQ's of 0.5 Mg Trametinib Tablets:

Q: How should 0.5 Mg Trametinib Tablets be administered?

A: These tablets are intended for oral administration, ideally taken as directed by your oncologist. It is crucial to follow the prescribed schedule to achieve optimal results in cancer treatment.

Q: What are the primary indications for using 0.5 Mg Trametinib Tablets?

A: The tablets are indicated for the treatment of adults with metastatic melanoma and certain other cancers harboring BRAF V600E or V600K mutations. Always confirm mutation status and consult your oncologist.

Q: When is it necessary to consult a doctor before starting these tablets?

A: A consultation with an oncologist is mandatory before starting treatment, to assess suitability and determine if your cancer is appropriate for Trametinib therapy. Do not start without medical guidance.

Q: Where are 0.5 Mg Trametinib Tablets mainly supplied and exported?

A: These tablets are chiefly distributed, exported, and supplied to markets across North America, Europe, Asia, and Africa, with India serving as a central supply hub.

Q: What is the process for storing and handling these tablets?

A: Store below 30C, in a dry environment away from moisture and light. Ensure the packaging remains intact until use to maintain tablet stability throughout its 24-month shelf life.

Q: What are the notable side effects of Trametinib Tablets 0.5 mg?

A: Common side effects include rash, diarrhea, lymphedema, and fatigue. Always review the package insert for comprehensive details and inform your oncologist about any adverse reactions observed during therapy.

Tell us about your requirement